You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IIIA melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy

Active, not recruiting
  • Melanoma
    • The Woodlands, Texas
      Local Institution
    Jun 21, 2022

    Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

    Active, not recruiting
    • Metastatic Melanoma
    • +6 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 13, 2023

    Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

    Active, not recruiting
    • Stage III Cutaneous Melanoma AJCC v7
    • +4 more
    • Cryosurgery
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic
    Jan 3, 2023

    Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 25, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +5 more
    • Jacksonville, Florida
    • +2 more
    Oct 21, 2022

    Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

    Recruiting
    • Clinical Stage I Cutaneous Melanoma AJCC v8
    • +33 more
    • Informational Intervention
    • +4 more
    • Los Angeles, California
    • +4 more
    Dec 14, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +41 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 11, 2022

    Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Brain
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

    Recruiting
    • Clinical Stage 0 Cutaneous Melanoma AJCC v8
    • +43 more
    • Best Practice
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Toxicity and Symptom Burden in Chronic Cancer Survivors With

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +7 more
    • Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 6, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

    Active, not recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +20 more
    • Ipilimumab
    • +3 more
    • Tampa, Florida
    • +6 more
    Jan 13, 2023

    Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

    Completed
    Has Results
    • Stage III Cutaneous Melanoma AJCC v7
    • +5 more
    • Aldesleukin
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2022

    Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

    Recruiting
    • Advanced Bladder Carcinoma
    • +34 more
    • Atezolizumab
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 29, 2022

    BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

    Active, not recruiting
    • BRAF V600E Mutation Present
    • +9 more
    • Boston, Massachusetts
    • +1 more
    Jun 28, 2022

    Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

    Recruiting
    • Clinical Stage 0 Cutaneous Melanoma AJCC v8
    • +21 more
    • Informational Intervention
    • Survey Administration
    • New Brunswick, New Jersey
    • +1 more
    Apr 6, 2022

    Melanoma Trial in Fort Wayne, Barcelona (Nivolumab/rHuPH20, Nivolumab)

    Recruiting
    • Melanoma
    • Nivolumab/rHuPH20
    • Nivolumab
    • Fort Wayne, Indiana
    • +1 more
    May 10, 2022

    Pharmacogenomics Testing in Directing Optimal Use of Supportive

    Recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +45 more
    • Biospecimen Collection
    • +3 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Feb 3, 2022

    Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +66 more
    • Best Practice
    • +3 more
    • Fullerton, California
      Virginia K Crosson Cancer Center
    Jan 31, 2022

    Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

    Recruiting
    • Advanced Differentiated Thyroid Gland Carcinoma
    • +102 more
    • Cabozantinib S-malate
    • Nivolumab
    • Chicago, Illinois
    • +2 more
    Apr 5, 2022

    AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

    Recruiting
    • AIDS-Related Non-Hodgkin Lymphoma
    • +29 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Birmingham, Alabama
    • +12 more
    Aug 4, 2022

    Melanoma, Malignant Melanoma, Stage IIIA Melanoma Trial in Orange (procedure, other, drug)

    Completed
    Has Results
    • Melanoma
    • +4 more
    • therapeutic conventional surgery
    • +3 more
    • Orange, California
      Chao Family Comprehensive Cancer Center
    Dec 30, 2020

    BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Melanoma Trial in Boston (drug, biological, other)

    Terminated
    • BRAF V600E Mutation Present
    • +7 more
    • Boston, Massachusetts
    • +1 more
    Mar 9, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +129 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Apr 8, 2022

    Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +28 more
    • Conroe, Texas
    • +4 more
    Dec 5, 2022

    Metastatic Melanoma, Stage III Mucosal Melanoma of the Head and Neck, Stage IIIA Skin Melanoma Trial in New Brunswick

    Active, not recruiting
    • Metastatic Melanoma
    • +8 more
    • Aldesleukin
    • +2 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Sep 20, 2021